These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia. Colovic N, Tosic N, Aveic S, Djuric M, Milic N, Bumbasirevic V, Colovic M, Pavlovic S. Ann Hematol; 2007 Oct 01; 86(10):741-7. PubMed ID: 17579862 [Abstract] [Full Text] [Related]
6. Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation. Boehm A, Sperr WR, Leitner G, Worel N, Oehler L, Jaeger E, Mitterbauer M, Haas OA, Valent P, Kalhs P, Rabitsch W. Eur J Clin Invest; 2008 Dec 01; 38(12):945-52. PubMed ID: 19021720 [Abstract] [Full Text] [Related]
7. Flt3 internal tandem duplication and P-glycoprotein functionality in 171 patients with acute myeloid leukemia. Marzac C, Teyssandier I, Calendini O, Perrot JY, Faussat AM, Tang R, Casadevall N, Marie JP, Legrand O. Clin Cancer Res; 2006 Dec 01; 12(23):7018-24. PubMed ID: 17145823 [Abstract] [Full Text] [Related]
11. FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation. Yoshimoto G, Nagafuji K, Miyamoto T, Kinukawa N, Takase K, Eto T, Kato K, Hayashi S, Kamimura T, Ohno Y, Taniguchi S, Harada M. Bone Marrow Transplant; 2005 Dec 01; 36(11):977-83. PubMed ID: 16184177 [Abstract] [Full Text] [Related]
12. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications. Baldus CD, Thiede C, Soucek S, Bloomfield CD, Thiel E, Ehninger G. J Clin Oncol; 2006 Feb 10; 24(5):790-7. PubMed ID: 16418499 [Abstract] [Full Text] [Related]
13. Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype. Konoplev S, Rassidakis GZ, Estey E, Kantarjian H, Liakou CI, Huang X, Xiao L, Andreeff M, Konopleva M, Medeiros LJ. Cancer; 2007 Mar 15; 109(6):1152-6. PubMed ID: 17315232 [Abstract] [Full Text] [Related]
14. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches. Deschler B, de Witte T, Mertelsmann R, Lübbert M. Haematologica; 2006 Nov 15; 91(11):1513-22. PubMed ID: 17082009 [Abstract] [Full Text] [Related]
15. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group. Büchner T, Berdel WE, Haferlach C, Haferlach T, Schnittger S, Müller-Tidow C, Braess J, Spiekermann K, Kienast J, Staib P, Grüneisen A, Kern W, Reichle A, Maschmeyer G, Aul C, Lengfelder E, Sauerland MC, Heinecke A, Wörmann B, Hiddemann W. J Clin Oncol; 2009 Jan 01; 27(1):61-9. PubMed ID: 19047294 [Abstract] [Full Text] [Related]
16. Prognostic significance of foetal-like tyrosine kinase 3 mutation in Egyptian children with acute leukaemia. Al-Tonbary Y, Mansour AK, Ghazy H, Elghannam DM, Abd-Elghaffar HA. Int J Lab Hematol; 2009 Jun 01; 31(3):320-6. PubMed ID: 18336585 [Abstract] [Full Text] [Related]
17. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience. Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X. Cancer; 2008 Feb 01; 112(3):572-80. PubMed ID: 18085638 [Abstract] [Full Text] [Related]
18. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia. Pinheiro RF, de Sá Moreira E, Silva MR, Alberto FL, Chauffaille Mde L. Cancer Genet Cytogenet; 2008 Jun 01; 183(2):89-93. PubMed ID: 18503825 [Abstract] [Full Text] [Related]
19. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation. Rausei-Mills V, Chang KL, Gaal KK, Weiss LM, Huang Q. Am J Clin Pathol; 2008 Apr 01; 129(4):624-9. PubMed ID: 18343790 [Abstract] [Full Text] [Related]
20. Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML). Ravandi F, Jilani I, Estey E, Kantarjian H, Dey A, Aguilar C, Jitkaroon C, Giles F, O'Brien S, Keating M, Albitar M. Leuk Res; 2007 Jun 01; 31(6):791-7. PubMed ID: 17156841 [Abstract] [Full Text] [Related] Page: [Next] [New Search]